Avior Wealth Management LLC Trims Position in Avantor, Inc. (NYSE:AVTR)

Avior Wealth Management LLC lowered its stake in Avantor, Inc. (NYSE:AVTR - Free Report) by 67.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,470 shares of the company's stock after selling 19,342 shares during the period. Avior Wealth Management LLC's holdings in Avantor were worth $200,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the stock. MBB Public Markets I LLC purchased a new stake in shares of Avantor in the second quarter valued at approximately $1,018,000. The Manufacturers Life Insurance Company increased its holdings in shares of Avantor by 128.2% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 820,058 shares of the company's stock valued at $17,385,000 after acquiring an additional 460,691 shares during the period. Quarry LP lifted its position in shares of Avantor by 4,489.1% during the second quarter. Quarry LP now owns 6,333 shares of the company's stock valued at $134,000 after buying an additional 6,195 shares during the last quarter. Sanctuary Advisors LLC acquired a new position in shares of Avantor during the second quarter worth $783,000. Finally, American Trust grew its stake in shares of Avantor by 16.3% during the second quarter. American Trust now owns 15,426 shares of the company's stock worth $327,000 after acquiring an additional 2,165 shares during the last quarter. 95.08% of the stock is owned by institutional investors.

Avantor Stock Down 0.2 %

Avantor stock traded down $0.05 during midday trading on Tuesday, reaching $22.44. The company's stock had a trading volume of 4,171,856 shares, compared to its average volume of 4,822,739. The company has a market cap of $15.27 billion, a P/E ratio of 48.77, a P/E/G ratio of 3.53 and a beta of 1.28. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84. Avantor, Inc. has a fifty-two week low of $19.59 and a fifty-two week high of $28.00. The business has a 50-day simple moving average of $21.54 and a 200-day simple moving average of $23.44.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on AVTR shares. Raymond James reduced their price objective on Avantor from $29.00 to $26.00 and set an "outperform" rating for the company in a research note on Tuesday, January 21st. Robert W. Baird dropped their target price on shares of Avantor from $27.00 to $26.00 and set an "outperform" rating on the stock in a research report on Monday, October 28th. Wells Fargo & Company dropped their price objective on shares of Avantor from $30.00 to $28.00 and set an "overweight" rating for the company in a research note on Monday, October 28th. UBS Group reissued a "neutral" rating and issued a $25.00 price target (down previously from $29.00) on shares of Avantor in a research note on Friday, January 17th. Finally, Barclays decreased their price objective on shares of Avantor from $28.00 to $25.00 and set an "overweight" rating on the stock in a report on Friday, October 25th. Three investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $27.38.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.